Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

photo of William Dupont
June 5, 2023

Study discovers that tumor mutation burden predicts survival outcome

The expected course of a patient’s cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.

By Tom Wilemon
May 31, 2023

Liquid biopsy test may detect early-stage and low DNA-shedding cancers

Vanderbilt research shows that a liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers.

By Tom Wilemon
May 11, 2023

Lovly elected to American Association for Cancer Research board

Christine Lovly, MD, PhD, has been elected to the American Association for Cancer Research board of directors.

By Tom Wilemon
April 27, 2023

Trial combines novel therapies for head and neck cancer

Vanderbilt is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.

By Tom Wilemon
April 26, 2023

VICC Scientific Retreat focuses on emerging technologies

The Vanderbilt-Ingram Cancer Center 24th Annual Scientific Retreat will be held from 8:30 am to 3 pm, May 23, in the Vanderbilt Student Life Center.

By Tom Wilemon
Jordan Berlin, MD, was recognized for his leadership serving on an NCI team that researched and recommended changes to clinical trial protocols that expanded the role of advanced practice providers.
April 6, 2023

National Cancer Institute honors Berlin’s contributions, leadership

Vanderbilt’s Jordan Berlin, MD, is a 2022 recipient of the National Cancer Institute Director’s Award.

By Tom Wilemon
March 30, 2023

New treatment helps mitigate hair loss for chemotherapy patients

Vanderbilt-Ingram Cancer Center has started offering scalp cooling, which mitigates hair loss for patients receiving certain chemotherapy regimens.
By Tom Wilemon
March 16, 2023

Soothing sounds

Nashville pianist Ed Bazel, founder of The River of Calm music channel, recently played for patients in the waiting room of the Henry-Joyce Cancer Clinic at Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
March 16, 2023

Eng stresses need for clinical trial support at cancer forum

Vanderbilt's Cathy Eng, MD, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum.
By Tom Wilemon
March 9, 2023

Osterman named Associate Vice President for Research Informatics

Travis Osterman, DO, MS, has been appointed to a new role as Associate Vice President for Research Informatics at Vanderbilt University Medical Center.
By Mia Garchitorena-Scancarelli
March 7, 2023

Nicole Kidman and Keith Urban gift supports breast cancer clinical trials at Vanderbilt-Ingram Cancer Center

Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.
By Tom Wilemon
March 2, 2023

Eng invited to White House Cancer Moonshot forum

Vanderbilt's Cathy Eng, MD, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.
By Tom Wilemon
February 16, 2023

Breast cancer genetics: new insights

Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.
By Leigh MacMillan
1 2 3 4 5 … 55